The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors : Journal of Immunotherapy

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Brief Communication

The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors

Gowan, Cody C.*; Bartee, Mee Y.; Flores, Erica; Aksoy, Bulent A; Templeton, Conor§; Baillie, Kati; Happe, Myroslawa; Bartee, Eric

Author Information
Journal of Immunotherapy: November 1, 2022 - Volume - Issue - 10.1097/CJI.0000000000000444
doi: 10.1097/CJI.0000000000000444
  • Buy
  • SDC
  • PAP

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.